Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Zenosense Inc. (ZENO) Message Board

Zenosense, Inc. (ZENO) Addressing Lung Cancer Surv

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 53
Posted On: 04/07/2015 5:56:57 PM
Avatar
Posted By: QualityStocks
Zenosense, Inc. (ZENO) Addressing Lung Cancer Survivability with New Technology

Lung cancer is one of the most fatal types of cancers in the world today. In 2015 alone, the American Lung Association estimates that more than 158,000 Americans will die from lung cancer, outpacing the combined fatality numbers of colorectal, breast and prostate cancers. Despite these somber figures, many people whose cancer has been detected in the early stages have been cured. According to the American Cancer Society (ACA), more than 430,000 people are alive today despite having been previously diagnosed with lung cancer, largely as a result of early diagnosis. Zenosense, Inc. (OTCQB: ZENO), through its developmental commercial lung cancer detection devices, is closing in on a way to greatly increase survivability.

One of the most important factors to consider when weighing the survivability of lung cancer is the stage in which it is originally detected. Studies by the ACA indicate that patients who have their cancer diagnosed in Stages IA or IB have a survival rate of just less than 50 percent, but those numbers quickly take a turn for the worse in later stages. If detected in Stage IIA or IIB, for example, survivability drops to just 30 percent, which is a perfect illustration of the importance of early detection.

Unfortunately, current diagnostic tests are limited in their effectiveness. The most commonly utilized screening method is a low-dose spiral CT scan, but the costs associated with these tests can often lead patients to waste valuable time before receiving the critical diagnosis. Zenosense’s non-invasive early detection method, which is currently in clinical trials, could be just the breakthrough to turn the corner on lung cancer survivability.

Using inexpensive sensors, the company aims to detect distinctive volatile organic compounds associated with lung cancer in the exhaled breath of patients. With methods similar to those used by prostate cancer detecting canines, these electronic detection devices could represent a significant step toward a major healthcare breakthrough.

With less than 20 percent of lung cancer currently being detected in the relatively treatable Stage I, the medical market should be extremely receptive of a more effective diagnostic tool. As a result, the company has expressed tremendous confidence that a cost-effective lung cancer detector with accuracy meeting or exceeding that of low-dose CT scanning will have widespread appeal in the medical community. As the company continues testing in university hospitals around Madrid, Spain, be on the lookout for significant opportunities.

For more information on the company, visit www.zenosense.net

Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com


(0)
(0)




Zenosense Inc. (ZENO) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us